EnerSpar Corp. (TSE:NRX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
NurExone Biologic Inc. is showcasing its innovative ExoPTEN therapy, aimed at treating acute spinal cord injuries, at two prestigious September conferences. The company’s CEO will present their research in Boston and participate as a panelist in New York, signifying NurExone’s growing impact in regenerative medicine and exosome technology.
For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.
